{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:40:04Z","timestamp":1751535604583,"version":"3.41.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute of the National Institutes of Health","award":["3U54CA242646-04S2"],"award-info":[{"award-number":["3U54CA242646-04S2"]}]},{"name":"The Hispanic Alliance for Clinical and Translational Research","award":["U54GM133807"],"award-info":[{"award-number":["U54GM133807"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Advances in HIV treatments have prolonged the lifespan of people living with HIV (PLWH), thereby increasing the risk of chronic conditions such as HIV-related cancers. Clinical trials (CT) play an important role in advancing cancer care in PLWH. However, their underrepresentation in CT underscores the need for involvement of healthcare professionals in CT referrals. This study aims to describe healthcare professionals\u2019 perception of PLWH understanding of CT for HIV-related cancers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed survey data from a training activity provided to healthcare professionals (<jats:italic>n<\/jats:italic>\u2009=\u200982) from HIV-specialized clinics and other healthcare organizations in Puerto Rico to assess healthcare professionals\u2019 perception of PLWH knowledge regarding CT for HIV-related cancers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Most participants were allied healthcare professionals (39.0%) or social services professionals (43.9%), with 70.8% having 1\u201315 years of experience caring for PLWH. Most participants believed that PLWH had limited knowledge about HIV-related cancers (65.8%) and CT for these cancers (59.8%). Nearly a quarter (23.1%) of healthcare professionals reported hearing expressions of fear regarding CT from PLWH. Conversely, almost half (49.4%) heard positive comments or experiences about participating in CT. The training activity did not include physicians. Perceived barriers for participation of PLWH in CT, according to the healthcare professionals, included fear of the unknown (48.8%), stigma associated with the participation in HIV-related clinical trials (43.9%), and lack of knowledge (42.7%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>According to healthcare professionals, the participation of PLWH in HIV-related clinical trials could be affected by limited knowledge or awareness about their benefits. Training activities are needed to increase awareness, knowledge and improve the participation of PLWH in HIV-related CT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-23137-w","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:04:59Z","timestamp":1751533499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perception of healthcare professionals about the knowledge of people living with HIV regarding clinical trials for HIV-related cancers"],"prefix":"10.1186","volume":"25","author":[{"given":"Jessica","family":"Hern\u00e1ndez-Marrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanialy","family":"Rivera-Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela","family":"Bournigal-Feliciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Col\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Palefsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana P.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marievelisse","family":"Soto-Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"8","key":"23137_CR1","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1016\/S2352-3018(17)30086-3","volume":"4","author":"IT Katz","year":"2017","unstructured":"Katz IT, Maughan-Brown B. Improved life expectancy of people living with HIV: who is left behind? Lancet HIV. 2017;4(8):e324\u20136. https:\/\/doi.org\/10.1016\/S2352-3018(17)30086-3.","journal-title":"Lancet HIV"},{"issue":"11","key":"23137_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/nejmra1615896","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan R, Uldrick TS. HIV-Associated cancers and related diseases. N Engl J Med. 2018;378(11):1029\u201341. https:\/\/doi.org\/10.1056\/nejmra1615896.","journal-title":"N Engl J Med"},{"key":"23137_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1200\/JCO","volume":"36","author":"V Col\u00f3n-L\u00f3pez","year":"2017","unstructured":"Col\u00f3n-L\u00f3pez V, Shiels MS, Machin M, et al. Anal cancer risk among people with HIV infection in the united States. J Clin Oncol. 2017;36:68\u201375. https:\/\/doi.org\/10.1200\/JCO","journal-title":"J Clin Oncol"},{"issue":"23","key":"23137_CR4","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1002\/cncr.31702","volume":"124","author":"AP Ortiz","year":"2018","unstructured":"Ortiz AP, Engels EA, Nogueras-Gonz\u00e1lez GM, et al. Disparities in human papillomavirus\u2013related cancer incidence and survival among human immunodeficiency virus\u2013infected Hispanics living in the united States. Cancer. 2018;124(23):4520\u20138. https:\/\/doi.org\/10.1002\/cncr.31702.","journal-title":"Cancer"},{"issue":"12","key":"23137_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.7326\/M17-2499","volume":"168","author":"MS Shiels","year":"2018","unstructured":"Shiels MS, Islam JY, Rosenberg PS, Hall HI, Jacobson E, Engels EA. Projected cancer incidence rates and burden of incident cancer cases in HIV-Infected adults in the united States through 2030. Ann Intern Med. 2018;168(12):866\u201373. https:\/\/doi.org\/10.7326\/M17-2499","journal-title":"Ann Intern Med"},{"issue":"1","key":"23137_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/COH.0000000000000321","volume":"12","author":"RF Little","year":"2017","unstructured":"Little RF. Cancer clinical trials in persons with HIV infection. Curr Opin HIV AIDS. 2017;12(1):84\u20138. https:\/\/doi.org\/10.1097\/COH.0000000000000321.","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"23137_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","volume":"44","author":"LT Clark","year":"2019","unstructured":"Clark LT, Watkins L, Pi\u00f1a IL, et al. Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol. 2019;44(5):148\u201372. https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.11.002.","journal-title":"Curr Probl Cardiol"},{"issue":"2","key":"23137_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.14423\/SMJ.0000000000000234","volume":"108","author":"C Heumann","year":"2015","unstructured":"Heumann C, Cohn SE, Krishnan S, et al. Regional variation in HIV clinical trials participation in the United States. South Med J. 2015;108(2):107\u201316. https:\/\/doi.org\/10.14423\/SMJ.0000000000000234","journal-title":"South Med J"},{"key":"23137_CR9","doi-asserted-by":"publisher","unstructured":"Cruz G, Ramos-Cartagena JM, Torres-Russe JL, et al. Barriers and facilitators to anal cancer screening among people living with HIV in Puerto Rico. BMC Public Health. 2023;23(1). https:\/\/doi.org\/10.1186\/s12889-023-16847-6.","DOI":"10.1186\/s12889-023-16847-6"},{"issue":"4","key":"23137_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/hiv.13259","volume":"23","author":"N Courvoisier","year":"2022","unstructured":"Courvoisier N, Storari C, Lesage S, et al. Facilitators and barriers of women\u2019s participation in HIV clinical research in Switzerland: A qualitative study. HIV Med. 2022;23(4):441\u20137. https:\/\/doi.org\/10.1111\/hiv.13259.","journal-title":"HIV Med"},{"key":"23137_CR11","doi-asserted-by":"publisher","unstructured":"van Paassen P, Dijkstra M, Peay HL, et al. Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection. J Virus Erad. 2022;8(2). https:\/\/doi.org\/10.1016\/j.jve.2022.100072.","DOI":"10.1016\/j.jve.2022.100072"},{"issue":"2","key":"23137_CR12","first-page":"84","volume":"78","author":"AI Vines","year":"2017","unstructured":"Vines AI, Melvin CL, Hunter JC, Carlisle VA, Project ACCRUE: Exploring options to increase awareness of AIDS Malignancy Consortium Clinical Trials in North Carolina. NC Med J. 2017;78(2):84\u201391.","journal-title":"NC Med J"},{"issue":"5","key":"23137_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s10461-018-2330-z","volume":"23","author":"AP Ortiz","year":"2019","unstructured":"Ortiz AP, Machin M, Soto-Salgado M, et al. Effect of an educational video to increase calls and screening into an anal cancer clinical trial among HIV\u2009+\u2009Hispanics in PR: Results from a randomized controlled behavioral trial. AIDS Behav. 2019;23(5):1135\u201346. https:\/\/doi.org\/10.1007\/s10461-018-2330-z","journal-title":"AIDS Behav"},{"issue":"1","key":"23137_CR14","first-page":"50","volume":"13","author":"M Rivera-D\u00edaz","year":"2020","unstructured":"Rivera-D\u00edaz M, Ayala-Mar\u00edn AM, V\u00e9lez-Alamo C, Acevedo-Font\u00e1nez AI, Ar\u00e9valo M, Col\u00f3n-L\u00f3pez V. Knowledge, motivations and concerns about participation in breast cancer clinical trials in Puerto Rico. J Health Dispar Res Pract. 2020;13(1):50\u201366.","journal-title":"J Health Dispar Res Pract"},{"issue":"4","key":"23137_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/08897077.2021.1900987","volume":"42","author":"K Jaffe","year":"2021","unstructured":"Jaffe K, Nosova E, DeBeck K, Hayashi K, Milloy MJ, Richardson L. Trust in research physicians as a key dimension of randomized controlled trial participation in clinical addictions research. Subst Abus. 2021;42(4):927\u201334. https:\/\/doi.org\/10.1080\/08897077.2021.1900987.","journal-title":"Subst Abus"},{"issue":"48","key":"23137_CR16","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1016\/j.vaccine.2011.09.067","volume":"29","author":"L Nyblade","year":"2011","unstructured":"Nyblade L, Singh S, Ashburn K, Brady L, Olenja J. Once I begin to participate, people will run away from me: Understanding stigma as a barrier to HIV vaccine research participation in Kenya. Vaccine. 2011;29(48):8924\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.067.","journal-title":"Vaccine"},{"key":"23137_CR17","doi-asserted-by":"publisher","unstructured":"Madiba S, Ralebona E, Lowane M. Perceived stigma as a contextual barrier to early uptake of HIV testing, treatment initiation, and disclosure; the case of patients admitted with AIDS-related illness in a rural hospital in South Africa. Healthc (Switzerland). 2021;9(8). https:\/\/doi.org\/10.3390\/healthcare9080962.","DOI":"10.3390\/healthcare9080962"},{"key":"23137_CR18","doi-asserted-by":"publisher","unstructured":"Baer AR, Michaels M, Good MJ, Schapira L. Engaging referring physicians in the clinical trial process. J Oncol Pract. 2012;8(1). https:\/\/doi.org\/10.1200\/JOP.2011.000476.","DOI":"10.1200\/JOP.2011.000476"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23137-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23137-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23137-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:05:00Z","timestamp":1751533500000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23137-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23137"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23137-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the ethical principles outline in the Declaration of Helsinki. The study, the questionnaire and methodology was approved by a Human Research Ethics committee of the Institutional Review Board of the University of Puerto Rico Comprehensive Cancer Center. (Protocol # 2022-10-90). Informed consent was obtained from all individual participants prior to be included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2377"}}